204 related articles for article (PubMed ID: 32319600)
1. Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
Liu AG; Zhong JC; Chen G; He RQ; He YQ; Ma J; Yang LH; Wu XJ; Huang JT; Li JJ; Mo WJ; Qin XG
Int J Oncol; 2020 Jul; 57(1):122-138. PubMed ID: 32319600
[TBL] [Abstract][Full Text] [Related]
2. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
4. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
6. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
7. SAC3D1 activates Wnt/β‑catenin signalling in hepatocellular carcinoma.
Wang H; Shi X
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004462
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis
Piao HY; Guo S; Wang Y; Zhang J
World J Gastroenterol; 2019 Nov; 25(44):6508-6526. PubMed ID: 31802831
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
11. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Qi M; Yu B; Yu H; Li F
Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
[TBL] [Abstract][Full Text] [Related]
14. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
Nakamura S; Kanda M; Shimizu D; Sawaki K; Tanaka C; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Cancer Genomics Proteomics; 2020; 17(5):509-516. PubMed ID: 32859629
[TBL] [Abstract][Full Text] [Related]
15. Identification of biomarkers for diagnosis of gastric cancer by bioinformatics.
Wang DG; Chen G; Wen XY; Wang D; Cheng ZH; Sun SQ
Asian Pac J Cancer Prev; 2015; 16(4):1361-5. PubMed ID: 25743799
[TBL] [Abstract][Full Text] [Related]
16. High FAM189B Expression and Its Prognostic Value in Patients with Gastric Cancer.
Wu CL; Tan QX; Liu D; Jiang JE; Lu T; Huang ZM; Su YJ
Biomed Res Int; 2021; 2021():8875971. PubMed ID: 34124264
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
18. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
Zhao Z; Zhang C; Zhao Q
Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
[No Abstract] [Full Text] [Related]
19. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
Li D; Zhang J; Xi Y; Zhang L; Li W; Cui J; Xing R; Pan Y; Pan Z; Li F; Lu Y
BMC Cancer; 2015 Sep; 15():637. PubMed ID: 26373288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]